Trends in Treatment and Perioperative Outcomes of Upper Tract Urothelial Carcinoma: The Evolving Role of Lymphadenectomy and Neoadjuvant Chemotherapy
Authors:
- Robert BischoffRBRobert Bischoff
- Nikolaos PyrgidisNPNikolaos Pyrgidis
- Benedikt EbnerBEBenedikt Ebner
- Yannic VolzYVYannic Volz
- Julian HermansJHJulian Hermans
- Marie SemmlerMSMarie Semmler
- Patrick KellerPKPatrick Keller
- Gerald B. SchulzGSGerald B. Schulz
- Julian MarconJMJulian Marcon
- Philipp WeinholdPWPhilipp Weinhold
- Christian G. StiefCSChristian G. Stief
- Lennert EismannLELennert Eismann
Open Access
- 26 March 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (7) , 2536
Abstract
Objectives: Real-world data on surgical and multimodal management of upper tract urothelial carcinoma (UTUC) are limited. This study examined epidemiological trends, nephron-sparing surgery adoption, and the perioperative impact of lymphadenectomy (LND) and neoadjuvant chemotherapy (NAC). Methods: The German Nationwide Inpatient Data (GRAND) registry (2005–2023) identified UTUC patients undergoing radical nephroureterectomy (RNU), endoscopic laser destruction, or segmental ureteral resection (SUR) using OPS codes. Demographics, comorbidities, complications, and in-hospital mortality were extracted from ICD-10-GM data. Multivariable regression adjusted for baseline comorbidities assessed associations between treatment type, LND, NAC, and perioperative outcomes. Results: Among 53,427 UTUC patients, 77.3% underwent RNU, 13.8% endoscopic laser destruction, and 8.9% SUR. Endoscopic laser use rose from <10% (2005) to about 20% (2023). LND was performed in 13% of RNU cases, increasing from 1.1% to 19%. LND was associated with higher risks of transfusion (OR 1.47, 95% CI 1.37–1.57), acute kidney injury (OR 1.19, 95% CI 1.07–1.32), and ICU admission (OR 1.21, 95% CI 1.13–1.30), without affecting in-hospital mortality. NAC was given to 1.7% of patients, with a five-fold increase over time, and was associated with more transfusions (OR 1.28, 95% CI 1.07–1.52) and urinomas (OR 2.31, 95% CI 1.31–3.78), but not mortality. Conclusions: UTUC management is evolving, with growing use of endoscopic laser therapy and guideline-aligned lymphadenectomy during nephroureterectomy. Neoadjuvant chemotherapy remains underused despite acceptable perioperative safety, highlighting the need for increased awareness to optimize multimodal treatment.Keywords
This publication has 31 references indexed in Scilit:
- Evolution of Robotic Urology in Clinical Practice from the Beginning to Now: Results from the GRAND Study RegisterEuropean Urology Focus, 2024
- Current Evidence on Utility, Outcomes, and Limitations of Endoscopic Laser Ablation for Localized Upper Urinary Tract Urothelial Carcinoma: Results from a Scoping ReviewEuropean Urology Open Science, 2023
- Location of Retroperitoneal Lymph Node Metastases in Upper Tract Urothelial Carcinoma: Results from a Prospective Lymph Node Mapping StudyEuropean Urology Open Science, 2023
- Upper tract urothelial carcinoma in Germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019World Journal of Urology, 2022
- Effectiveness and Safety of Thulium Fiber Laser in the Conservative Management of Patients with Upper Tract Urothelial CarcinomaEuropean Urology Open Science, 2022
- Segmental Ureterectomy Versus Radical Nephroureterectomy in Older Patients Treated for Upper Tract Urothelial CarcinomaClinical Genitourinary Cancer, 2022
- Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non–muscle-invasive Bladder CancerEuropean Urology Focus, 2019
- An Analysis of Staging and Treatment Trends for Upper Tract Urothelial Carcinoma in the National Cancer DatabaseClinical Genitourinary Cancer, 2018
- Genomic Characterization of Upper Tract Urothelial CarcinomaEuropean Urology, 2015
- European Guidelines for the Diagnosis and Management of Upper Urinary Tract Urothelial Cell Carcinomas: 2011 UpdateEuropean Urology, 2011